Pemetrexed (LY-231514, LY231514),又称培美曲塞、培美曲塞酸、培美曲塞二酸或培美曲赛酸,是一种新型抗叶酸和抗代谢药物,通过破坏细胞内叶酸依赖性的正常代谢过程来抑制细胞生长。Pemetrexed作用于DHFR、TS和GARFT,Ki分别为7.2 nM、1.3 nM和65 nM。培美曲塞常与顺铂联合用于局部晚期或者转移性非鳞状细胞型非小细胞肺癌治疗。
参考文献
1.Shih C, et al. LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res. 1997 Mar 15;57(6):1116-23.
2.Iwahori K, et al. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma. Int J Cancer. 2013 Jan 15;132(2):459-71.
3.Teicher BA, et al. Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts. Clin Cancer Res. 2000 Mar;6(3):1016-23.
冰袋运输。粉末直接保存于-20℃,有效期3年。建议分装后-20℃干燥保存,避免反复冻融。